Published by Science and Education Publishing

Author: Ferdous Ara Begum, Md Arifur Rahman, Mohammed Kamal, Qamruzzaman Chowdhury


Involvement of NHL in ovary is seen in disseminated Lymphoma but primary ovarian lymphoma still not commonly seen. We presented the case where the patient had suffered for unexplained fever for more than 1 year and lately presented with gross weight loss as well as painless lower abdominal lump. CT scan showed a huge heterogeneous mass of about 15×12.4cm in pelvic cavity with mild ascites. Surgery was performed in view of ovarian neoplasm as CA125 was also raised. Histopathology confirmed the diagnosis of diffuse large B cell lymphoma with Immunohistochemistry confirmation. Treated with R-CHOP protocol for 6 cycles as IHC expressed CD20 positive. Post chemotherapy follow up PET scan showed complete response of treatment, though in spite of all treatment Primary ovarian lymphoma have a poor outcome with a range from 0% to 36% expected to survive for less than three years.

Figure 1: CT Scan Axis
CT Scan Axial
Figure 2: CT Scan Coronal
CT Scan Coronal
Figure 3: Histopathology
Figure 4: IHC (BCL2 & CD20)
IHC (BCL2 & CD20)


[1]  M. A. Dimopoulos, D. Daliani, W. Pugh, D. Gershenson, F. Cabanillas, and A. H. Sarris, “Primary ovarian non-Hodgkin’s lymphoma: outcome after treatment with combination chemotherapy,” Gynecologic Oncology, vol. 64, no. 3, pp. 446-450, 1997.     
[2]  Monterroso, E. S. Jaffe, M. J. Merino, and L. J. Medeiros, “Malignant lymphomas involving the ovary: a clinicopathologic analysis of 39 cases,” American Journal of Surgical Pathology, vol.17, no. 2, pp. 154-170, 1993.
[3]  I. Chorlton, H. J. Norris, and F. M. King, “Malignant reticuloendothelial disease involving the ovary as a primary manifestation. A series of 19 lymphomas and 1 granulocytic sarcoma,” Cancer, vol. 34, no. 2, pp. 397-407, 1974.
[4]  Hussell T, Isaacson PG, Crabtree JE, Spencer J. The response of cells from low-grade B-cell gastric lymphomas of mucosaassociated lymphoid tissue to Helicobacter pylori. Lancet 1993; 4:571-4.
[5]  H. Fox, F. A. Langley, A. D. T. Govan, S. A. Hill, and M.H. Bennett, “Malignant lymphoma presenting as an ovarian tumour: a clinicopathological analysis of 34 cases,” British Journal of Obstetrics and Gynaecology, vol. 95, no. 4, pp. 386-390, 1988.
[6]  Russell Vang, M.D., L. Jeffrey Medeiros, M.D., Roger A. Warnke, M.D., John P. Higgins, M.D.,Michael T. Deavers, M.D, “Ovarian Non-Hodgkin’s Lymphoma: A Clinicopathologic Study of Eight Primary Cases” Modern Pathology, Mod Pathol 2001; 14(11): 1093-1099, VOL. 14, NO. 11, P. 1093, 2001
[7]  N. Sakurai, K. Tateoka, J. Taguchi, and T. Terada, “Primary precursor B-cell lymphoblastic lymphoma of the ovary: case report and review of the literature,” International Journal of Gynecological Pathology, vol. 27, no. 3, pp. 412-417, 2008.
[8]  Suresh Babu1, Usha Amirtham2, Lokesh K.N1, Govind Babu.K1, Lakshmaiah K.C1, Lokanatha Dasappa1, C.S. Premalata2, Linu Abraham Jacob1, Rudresh AH1, Rajeev LK1, Venugopal Arroju1, “Ovarian Non-Hodgkin’s Lymphoma from a Regional Cancer Centre in South India” International Journal of Science, Vol- 5, Issued- 2016(05).
[9]  M. A. Dimopoulos, D. Daliani, W. Pugh, D. Gershenson, F.Cabanillas, and A. H. Sarris, “Primary ovarian non-Hodgkin’slymphoma: outcome after treatment with combination chemotherapy,” Gynecologic Oncology, vol. 64, no. 3, pp. 446-450, 1997.




Please enter your comment!
Please enter your name here